Investigative Urology - Results from #6740

Interactions between genetic variants and breast cancer risk factors in the Breast and Prostate Cancer Cohort Consortium - Abstract August 18, 2011

A phase I study of combined docetaxel and repeated high activity (186)Re-HEDP in castration-resistant prostate cancer (CRPC) metastatic to bone (the TAXIUM trial) - Abstract August 18, 2011

Correlation of phospholipid metabolites with prostate cancer pathologic grade, proliferative status and surgical stage - impact of tissue environment - Abstract August 18, 2011

Randomized phase 2 trial of custirsen (OGX-011) with docetaxel or mitoxantrone in patients with metastatic castrate-resistant prostate cancer: CUOG Trial P06c - Abstract August 16, 2011

A phase II study of sorafenib in combination with bicalutamide in patients with chemotherapy-naive castration resistant prostate cancer - Abstract August 15, 2011

p53 and cyclooxygenase-2 expression are directly associated with cyclin D1 expression in radical prostatectomy specimens of patients with hormone-naïve prostate cancer - Abstract August 15, 2011

Role of (11)C-choline positron emission tomography/computed tomography in evaluating patients affected by prostate cancer with suspected relapse due to prostate-specific antigen elevation - Abstract August 15, 2011

Editor's Commentary - SLCO2B1 and SLCO1B3 may determine time to progression for patients receiving androgen deprivation therapy for prostate cancer August 15, 2011

Plasma and tissue insulin-like growth factor-I receptor (IGF-IR) as a prognostic marker for prostate cancer and anti-IGF-IR agents as novel therapeutic strategy for refractory cases: A review - Abstract August 12, 2011

Eastern Cooperative Oncology Group Phase II Trial of lapatinib in men with biochemically relapsed, androgen dependent prostate cancer - Abstract August 12, 2011

Serum 25-hydroxyvitamin D and prostate cancer risk in a large nested case-control study - Abstract August 12, 2011

Androgen deprivation therapy affects BCL-2 expression in human prostate cancer - Abstract August 12, 2011

Curcumin-induced mitotic spindle defect and cell cycle arrest in human bladder cancer cells is partly through inhibition of Aurora-A - Abstract August 11, 2011

Time-dependent changes in bladder function and plantar sensitivity in a rat model of fibromyalgia syndrome induced by hydrochloric acid injection into the gluteus - Abstract August 11, 2011

SLCO2B1 and SLCO1B3 may determine time to progression for patients receiving androgen deprivation therapy for prostate cancer - Abstract August 11, 2011

Polymorphisms in androgen signaling pathway predisposing to prostate cancer - Abstract August 11, 2011

A randomized phase IIb presurgical study of finasteride vs. low-dose flutamide vs. placebo in men with prostate cancer. Efficacy monitored by karyometry - Abstract August 11, 2011

A role for OCT4 in tumor initiation of drug-resistant prostate cancer cells - Abstract August 10, 2011

Andrographolide targets androgen receptor pathway in castration-resistant prostate cancer - Abstract August 10, 2011

The hedgehog/Gli signaling paradigm in prostate cancer - Abstract August 9, 2011

Page 338 of 346